High Monounsaturated Fatty Acids Intake Protects Against Age-Related Cognitive Decline
Neurol 52:1563-1569, Solfrizzi,V.,et al, 1999

Cost-Effectiveness of Donepezil in the Treatment of Mild or Moderate Alzheimer's Disease
Neurol 52:1138-1145,1115, Neumann,P,J.,et al, 1999

Rapidly Progressive Dementia
Lancet 353:1150, Bornke,C.,et al, 1999

Clinicopath Conf:Multisystem Neurodegenerative Disease with Dementia Pugilistica
NEJM 340:1269-1277, Case 12-1999, 1999

Abnormal Diffusion-Weighted Magnetic Resonance Images in Creutzfeldt-Jakob Disease
Arch Neurol 56:577-583, Bahn,M.M.,&Parchi,P., 1999

Mortality from Dementia in Occupations at Risk of Exposure to Bovine Spongiform EncephalopathyAnalysis of Death Registrations
BMJ 318:1044-1045, Aylin,P.,et al, 1999

Prevalence and Clinical Correlates of Psychotic Symptoms in parkinson Disease
Arch Neurol 56:595-601, Aarsland,D.,et al, 1999

Infantile Neuroaxonal Dystrophy,Clinical Spectrum and Diagnostic Criteria
Neurol 52:1472-1478, Nardocci,N.,et al, 1999

Medial Temporal Lobe Atrophy on MRI in Dementia with Lewy Bodies
Neurol 52:1153-1158, Barber,R.,et al, 1999

Clinicopath Conf:Lymphoplasmocytic Lymphoma with Motor Neuronopathy,Waldenstrom's Macroglobulinemia
NEJM 340:1661-1669, , 1999

Multiple large and Small Cerebellar Infarcts
JNNP 66:739-745, Sanaple,S.&Bogousslavsky,J., 1999

Prion Protein Conformation in a Patient with Sporadic Fatal Insomnia
NEJM 340:1630-1638,1675, Mastrianni,J.A.,et al, 1999

Do We Have Drugs for Dementia? No
Arch Neurol 56:735-737, Pryse-Phillips,W., 1999

Do We Have a Treatment for Alzheimer Disease? Yes
Arch Neurol 56:738-739,735, Gauthier,S., 1999

Sneddon's Syndrome:Neuro-Ophthalmologic Manifestations in a Possible Autosomal Recessive Pattern
Neurol 51:1185-1187, Rehany,U.,et al, 1998

Creutzfeldt-Jakob Disease and Related Transmissible Spongiform Encephalopathies
NEJM 339:1994-2004, Johnson,R.T. & Gibbs,Jr.,C.J., 1998

Post-Traumatic Shoulder 'Dystonia':Persistent Abnormal Postures of the Shoulder After Minor Trauma
Neurol 51:1205-1207, Thyagarajan,D.,et al, 1998

The Efficacy of Ginkgo Biloba on Cognitive Function in Alzheimer Disease
Arch Neurol 55:1409-1415, Oken,B.S.,et al,, 1998

Olfactory Dysfunction in Guamanian ALS,Parkinsonism,and Dementia
Neurol 51:1672-1677, Ahlskog,J.E.,et al, 1998

Dementia with Lewy Bodies:Response of Delirium-Like Features to Donepezil
Neurol 51:1512, Kaufer,D.I.,et al, 1998

New Neuropathological Criteria for Alzheimer Disease
Arch Neurol 55:1174-1176, Hyman,B.T., 1998

Early Dopaminergic Drug-Induced Hallucinations in Parkinsonian Patients
Neurol 51:811-814, Goetz,C.G.,et al, 1998

Warfarin Use Following Ischemic Stroke Among Medicare Patients with Atrial Fibrillation
Arch Int Med 158:2093-2100, Brass,L.A.,et al, 1998

Long-Term Risk of First Recurrent Stroke in the Perth Community Stroke Study
Stroke 29:2491-2500, Hankey,G.J.,et al, 1998

Clinicopath Conf
Dementia with Lewy Bodies, Anaplastic Astrocytoma of Right Insular Region, Case 7-1998, NEJM 338:603, 61098., 1998

Imaging the Brain, Part 1 & 2
NEJM 338:812-820, 889-8961998., Gilman,S., 1998

Middle Cerebral Artery Main Stem Thrombosis in Two Siblings with Familial Thrombotic Thrombocytopenic Purpura
Neurol 50:1157-1160, Kelly,P.J.,et al, 1998

Cerebral Infarction in Young Adults
Neurol 50:890-894, Kittner,S.J.,et al, 1998

Clinical Features of Moyamoya Disease in the United States
Stroke 29:1347-1351, Chiu,D.,et al, 1998

Mechanisms of Second and Further Strokes
JNNP 64:771-776, 7161998., Yamamoto,H.&Bogousslavsky,J., 1998

Dolichoectasia of the Intracranial Arteries in Patients with First Ischemic Stroke, A Population-Based Study
Neurol 50:1694-1698, Ince,B.,et al, 1998

Hydrogen Peroxide Poisoning Causing Brain Infararction:Neuroimaging Findings
AJR 170:1653-1655, Ashdown,B.C.,et al, 1998

Atrial Fibrillation is an Independent Determinant of Low Cognitive Function
Stroke 29:1816-1820, Kilander,L.,et al, 1998

Progression of Alzheimer's Disease in Black and White Patients
Neurol 51:154-158, Fillenbaum,G.G.,et al, 1998

Lack of Relation Between Race and Cognitive Test Performance in Alzheimer's Disease
Neurol 50:1499-1501, Carlson,M.G.,et al, 1998

Clinical Presentation and Pharmacological Therapy in Corticobasal Degeneration
Arch Neurol 55:957-961, Kompoliti,K.,et al, 1998

Fluid Attenuation Inversion Recovery (FLAIR) Images of Dentatorubropalliodoluysian Atrophy:Case Report
JNNP 65:396-399, Yoshii,F.,et al, 1998

Genetic Studies on Chromosome 12 in Late-Onset Alzheimer Disease
JAMA 280:619-622, 6521998., Wu,W.S.,et al, 1998

Evidence for an Alzheimer Disease Susceptability Locus on Chromosome 12 and for Further Locus Heterogeneity
JAMA 280:614-618, 6521998., Rogaeva,E.,et al, 1998

Pharmacologic Treatment of Cognition in Alzheimer's Dementia
Neurol 51:S36-S44, Farlow,M.R.&Evans,R.M., 1998

Donepezil Improves Cognition & Global Function in Alzheimer Dis, 15-Week Doub-Blind, Plac-Contr Study
Arch Int Med 158:1021-1031, 9411998., Rogers,S.L.,et al, 1998

Is Exposure to Aluminum a Risk Factor for the Development of Alzheimer Disease? -Yes
Neurol 55:740-742, Forbes,W.F.&Hill,G.B., 1998

Is Exposure to Aluminum a Risk Factor for the Development of Alzheimer Disease? -No
Arch Neurol 55:737-739, 7421998., Munoz,D.G., 1998

Preclinical Prediction of Alzheimer's Disease Using SPECT
Neurol 50:1563-1571, Johnson,K.A.,et al, 1998

Smoking and Risk of Dementia and Alzheimer's Disease in a Population-Based Cohort Study:The Rotterdam Study
lancet 351:1840-1843, Ott,A.,et al, 1998

Nonsteroidal Anti-Inflammatory Drug use and Alzheimer-Type Pathology in Aging
Neurol 50:986-990, Mackenzie,I.&Munoz,D.G., 1998

A Permanent Pure Amnestic Syndrome of Isidious Onset Related to Alzheimer's Disease
Ann Neurol 43:526-530, Didic,M.,et al, 1998

Familial Aggregation in Frontotemporal Dementia
Neurol 50:1541-1545, Stevens,M.,et al, 1998

Longitudinal Study of CSF Levels of Tau, A beta 1-40, and A beta 1-42 (43) in Alzheimer's Disease
Ann Neurol 44:17-26, 61998., Kanai,M.,et al, 1998

Ginkgo Biloba for Dementia
The Medical Letter 40:63-64, , 1998